Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Thomas C. Tsai, Gabriela G. Lee, Amanda Ting, Michael H. Antoni, Armando Mendez, Charles S. Carver & Youngmee Kim. (2023) Roles of benefit finding in psychological and inflammatory adjustments in persons with colorectal cancer: a prospective analysis on the multidimensionality of benefit finding. Psychology & Health 0:0, pages 1-19.
Read now
Read now
Ruhee A. Patel, Whitney Wharton, Allison A. Bay, Liang Ni, Jolie D. Barter & Madeleine E. Hackney. (2020) Association between anti-inflammatory interleukin-10 and executive function in African American women at risk for Alzheimer’s disease. Journal of Clinical and Experimental Neuropsychology 42:7, pages 647-659.
Read now
Read now
Renuka , Navneet Agnihotri, Ajit Pal Singh & Archana Bhatnagar. (2016) Involvement of Regulatory T Cells and Their Cytokines Repertoire in Chemopreventive Action of Fish Oil in Experimental Colon Cancer. Nutrition and Cancer 68:7, pages 1181-1191.
Read now
Read now
Ewa Bien, Malgorzata Krawczyk, Ewa Izycka-Swieszewska, Piotr Trzonkowski, Bernarda Kazanowska, Elzbieta Adamkiewicz-Drozynska & Anna Balcerska. (2013) Deregulated systemic IL-10/IL-12 balance in advanced and poor prognosis paediatric soft tissue sarcomas. Biomarkers 18:3, pages 204-215.
Read now
Read now
Mona R. Hassuneh, Mitzi Nagarkatti & Prakash S. Nagarkatti. (2013) Role of interleukin-10 in the regulation of tumorigenicity of a T cell lymphoma. Leukemia & Lymphoma 54:4, pages 827-834.
Read now
Read now
Henry B Koon & Michael B Atkins. (2007) Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance. Expert Review of Anticancer Therapy 7:1, pages 79-88.
Read now
Read now
Articles from other publishers (89)
Marco Carlo Merlano, Matteo Paccagnella, Nerina Denaro, Andrea Abbona, Danilo Galizia, Dario Sangiolo, Loretta Gammaitoni, Erika Fiorino, Silvia Minei, Paolo Bossi, Lisa Licitra & Ornella Garrone. (2023) Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment. Cancers 15:21, pages 5257.
Crossref
Crossref
Qingkai Dai, Ge Zhang, Yuefang Wang, Lei Ye, Rui Shi, Luyun Peng, Siqi Guo, Jiajing He, Hao Yang, Yingjun Zhang & Yongmei Jiang. (2023) Cytokine network imbalance in children with B-cell acute lymphoblastic leukemia at diagnosis. Cytokine 169, pages 156267.
Crossref
Crossref
Lindsay Kathleen Dickerson, Jason A Carter, Karan Kohli & Venu G Pillarisetty. (2023) Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours. Gut 72:8, pages 1592-1606.
Crossref
Crossref
Mikyung Kang, Han Young Kim & Suk Ho Bhang. (2023) T-cell membrane coating for improving polymeric nanoparticle-based cancer therapy. Journal of Industrial and Engineering Chemistry 119, pages 252-260.
Crossref
Crossref
J. Magarian Blander, Kristel Joy Yee Mon, Atimukta Jha & Dylan Roycroft. 2023.
33
114
.
Seyed Amir Sanatkar, Arash Heidari & Nima Rezaei. (2022) Cancer Immunotherapy: Diverse Approaches and Obstacles. Current Pharmaceutical Design 28:29, pages 2387-2403.
Crossref
Crossref
Olga V. Zhukova, Evgenia V. Arkhipova, Tatiana F. Kovaleva, Daria A. Zykova & Natalya A. Dubovskaya. (2022) Effect of Poly(methacrylic acid) on the Cytokine Level in an In Vivo Tumor Model. Molecules 27:14, pages 4572.
Crossref
Crossref
Jia Huo, Lijun Fu, Mengyuan Jin, Zhaoming Li & Mingzhi Zhang. (2022) IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4. Investigational New Drugs 40:3, pages 537-545.
Crossref
Crossref
Uğur Çakır, Anna Hajdara, Balázs Széky, Balázs Mayer, Sarolta Kárpáti, Éva Mezey, Pálma Silló, Gergely Szakács, András Füredi, Zoltán Pós, Barbara Érsek, Miklós Sárdy & Krisztián Németh. (2021) Mesenchymal-Stromal Cell-like Melanoma-Associated Fibroblasts Increase IL-10 Production by Macrophages in a Cyclooxygenase/Indoleamine 2,3-Dioxygenase-Dependent Manner. Cancers 13:24, pages 6173.
Crossref
Crossref
Elena Y. Komarova, Roman V. Suezov, Alina D. Nikotina, Nikolay D. Aksenov, Luiza A. Garaeva, Tatiana A. Shtam, Alexander V. Zhakhov, Marina G. Martynova, Olga A. Bystrova, Maria S. Istomina, Alexander M. Ischenko, Boris A. Margulis & Irina V. Guzhova. (2021) Hsp70-containing extracellular vesicles are capable of activating of adaptive immunity in models of mouse melanoma and colon carcinoma. Scientific Reports 11:1.
Crossref
Crossref
Lucía Angélica Méndez-García, Halili Minor-Borrego, Ana Laura Sánchez-Del Real, José Alfredo Aguayo-Guerrero, Tania Alvarado-Monroy, Fernanda Trejo-Millán, Jahaziel Rosas-Salinas, Salma Alejandra Rizo-Tellez, Sergio Islas-Andrade, Juan Carlos Briones-Garduño, José Manuel Fragoso & Galileo Escobedo. (2021) Cord blood levels of interleukin-10 decrease in neonates with increased birth weight: novel implications of the cytokine network in early obesity. European Journal of Pediatrics 180:8, pages 2529-2537.
Crossref
Crossref
Fábio Magalhães-Gama, Marlon Wendell Athaydes Kerr, Nilberto Dias de Araújo, Hiochelson Najibe Santos Ibiapina, Juliana Costa Ferreira Neves, Fabíola Silva Alves Hanna, Lilyane de Amorim Xabregas, Maria Perpétuo Socorro Sampaio Carvalho, Eliana Brasil Alves, Andréa Monteiro Tarragô, Olindo Assis Martins-Filho, Andréa Teixeira-Carvalho, Adriana Malheiro & Allyson Guimarães da Costa. (2021) Imbalance of Chemokines and Cytokines in the Bone Marrow Microenvironment of Children with B-Cell Acute Lymphoblastic Leukemia. Journal of Oncology 2021, pages 1-9.
Crossref
Crossref
Maria Teresa Gonzalez-Garza, Delia Elva Cruz-Vega & Carmen Maldonado-Bernal. 2021. Translational Research in Cancer. Translational Research in Cancer.
Dandan Bao, Chenghao Zhang, Longlong Li, Haihong Wang, Qiuyan Li, Leilei Ni, Yinfeng Lin, Rong Huang, Zhangwei Yang, Yan Zhang & Yiren Hu. (2021) Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Emilio Francesco Giunta, Giusi Barra, Vincenzo De Falco, Giuseppe Argenziano, Stefania Napolitano, Pasquale Vitale, Nicoletta Zanaletti, Marinella Terminiello, Erika Martinelli, Floriana Morgillo, Davide Ciardiello, Raffaele De Palma, Fortunato Ciardiello & Teresa Troiani. (2020) Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients. Scientific Reports 10:1.
Crossref
Crossref
Bruna C. Bertol, Jéssica N. G. Araújo, Ibrahim A. Sadissou, Paulin Sonon, Fabrício C. Dias, Raul H. Bortolin, Nathalie L. Figueiredo‐Feitosa, Luiz C. Conti Freitas, Sheila R. Miranda Henrique Tarrapp, Carlos C. Oliveira Ramos, André D. Luchessi, Janaina C. O. C. Freitas, Léa M. Z. Maciel, Vivian N. Silbiger & Eduardo A. Donadi. (2020) Plasma levels of soluble HLA‐G and cytokines in papillary thyroid carcinoma before and after thyroidectomy. International Journal of Clinical Practice 74:10.
Crossref
Crossref
Reem Saleh & Eyad Elkord. (2020) FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets. Cancer Letters 490, pages 174-185.
Crossref
Crossref
Faiza Nessark, Mohamed Eissa, Abdoullatif Baraket, Nadia Zine, Belkacem Nessark, Ahmed Zouaoui, Joan Bausells & Abdelhamid Errachid. (2020) Capacitance Polypyrrole‐based Impedimetric Immunosensor for Interleukin‐10 Cytokine Detection. Electroanalysis 32:8, pages 1795-1806.
Crossref
Crossref
Margarida Saraiva, Paulo Vieira & Anne O’Garra. (2020) Biology and therapeutic potential of interleukin-10. Journal of Experimental Medicine 217:1.
Crossref
Crossref
Alessia Paganelli, Federico Garbarino, Paola Toto, Giuseppe Di Martino, Marika D’Urbano, Matteo Auriemma, Pamela Di Giovanni, Fabrizio Panarese, Tommaso Staniscia, Paolo Amerio & Roberto Paganelli. (2019) Serological landscape of cytokines in cutaneous melanoma. Cancer Biomarkers 26:3, pages 333-342.
Crossref
Crossref
Afsane Bahrami, Mohammad Fereidouni, Matteo Pirro, Vanessa Bianconi & Amirhossein Sahebkar. (2019) Modulation of regulatory T cells by natural products in cancer. Cancer Letters 459, pages 72-85.
Crossref
Crossref
Xiaoting Wang, Kit Wong, Wenjun Ouyang & Sascha Rutz. (2019) Targeting IL-10 Family Cytokines for the Treatment of Human Diseases. Cold Spring Harbor Perspectives in Biology 11:2, pages a028548.
Crossref
Crossref
Sandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, Samer Sansil, Anthony D. Pomicter, Maria E. Balasis, John Robinson, Jodi Kroeger, Qing Zhang, Yu Long Zhao, Markus Ball, Rami Komrokji, Alan List, Michael W. Deininger, Brooke L. Fridley, Valeria Santini, Eric Solary & Eric Padron. (2018) Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML. Leukemia 33:1, pages 205-216.
Crossref
Crossref
Denis Lane, Isabelle Matte, Perrine Garde-Granger, Paul Bessette & Alain Piché. (2018) Ascites IL-10 Promotes Ovarian Cancer Cell Migration. Cancer Microenvironment 11:2-3, pages 115-124.
Crossref
Crossref
Jonas Nørskov Søndergaard, Simon J. van Heeringen, Maaike W. G. Looman, Chunling Tang, Vassilis Triantis, Pauline Louche, Eva M. Janssen-Megens, Anieta M. Sieuwerts, John W. M. Martens, Colin Logie, Hendrik G. Stunnenberg, Marleen Ansems & Gosse J. Adema. (2018) Dendritic Cells Actively Limit Interleukin-10 Production Under Inflammatory Conditions via DC-SCRIPT and Dual-Specificity Phosphatase 4. Frontiers in Immunology 9.
Crossref
Crossref
Irina N. Mikhaylova, Irina Zh. Shubina, George Z. Chkadua, Natalia N. Petenko, Lidia F. Morozova, Olga S. Burova, Robert Sh. Beabelashvili, Kermen A. Parsunkova, Natalia V. Balatskaya, Dmitrii K. Chebanov, Vadim I. Pospelov, Valeria V. Nazarova, Anastasia S. Vihrova, Evgeny A. Cheremushkin, Alvina A. Molodyk, Mikhail V. Kiselevsky & Lev V. Demidov. (2018) Immunological monitoring for prediction of clinical response to antitumor vaccine therapy. Oncotarget 9:36, pages 24381-24390.
Crossref
Crossref
Xiulan Lai & Avner Friedman. (2017) Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model. BMC Systems Biology 11:1.
Crossref
Crossref
Lucas Leite Cunha, Elaine Cristina Morari, Sueli Nonogaki, Marjory Alana Marcello, Fernando Augusto Soares, José Vassallo & Laura Sterian Ward. (2016) Interleukin 10 expression is related to aggressiveness and poor prognosis of patients with thyroid cancer. Cancer Immunology, Immunotherapy 66:2, pages 141-148.
Crossref
Crossref
Tsung-I Hsu, Yi-Chang Wang, Chia-Yang Hung, Chun-Hui Yu, Wu-Chou Su, Wen-Chang Chang & Jan-Jong Hung. (2016) Positive feedback regulation between IL10 and EGFR promotes lung cancer formation. Oncotarget 7:15, pages 20840-20854.
Crossref
Crossref
Suidong Ouyang, Guangming Han, Xiaochu Wu, Zhengfan Jiang & Ji-Ming Feng. (2016) Accelerated progression of Hodgkin’s-like lymphomas in golli deficient SJL mice. Cellular Immunology 302, pages 41-49.
Crossref
Crossref
Anjana Kumari Negi, Renuka, Archana Bhatnagar & Navneet Agnihotri. (2016) Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer. Inflammopharmacology 24:1, pages 11-22.
Crossref
Crossref
Diego Antonio Costa Arantes, Nádia Lago Costa, Elismauro Francisco Mendonça, Tarcília Aparecida Silva & Aline Carvalho Batista. (2016) Overexpression of immunosuppressive cytokines is associated with poorer clinical stage of oral squamous cell carcinoma. Archives of Oral Biology 61, pages 28-35.
Crossref
Crossref
Paulo C. Rodriguez & Augusto C. Ochoa. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology
526
533
.
P. Cervera, A. Guihot, G. Gorochov, K. Lassoued & P. Coppo. (2015)
Epstein-Barr virus-driven B Cell Proliferation with CD4
+
T Cell Expansion: A Lymphomatoid Granulomatosis-like Disease Related to Hyperinterleukin-10 Secretion of Remarkably Favourable Outcome with Rituximab
. Scandinavian Journal of Immunology 82:6, pages 532-538.
Crossref
Crossref
Brigitta Mester, Evelyn Bauer, Catherine E. Wood, Ian F. Hermans & Olivier Gasser. (2015) Expression of CD1a and Type-1 Polarization Are Dissociated in Human Monocyte-Derived Dendritic Cells. PLOS ONE 10:10, pages e0140432.
Crossref
Crossref
Shuai Zhao, Dang Wu, Pin Wu, Zhen Wang & Jian Huang. (2015) Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis. PLOS ONE 10:10, pages e0139598.
Crossref
Crossref
Mark H. Mannino, Ziwen Zhu, Huaping Xiao, Qian Bai, Mark R. Wakefield & Yujiang Fang. (2015) The paradoxical role of IL-10 in immunity and cancer. Cancer Letters 367:2, pages 103-107.
Crossref
Crossref
Tiansuo Zhao, He Ren, Xiuchao Wang, Pengfei Liu, Fan Yan, Wenna Jiang, Yang Li, Jing Li, John G. Gribben, Li Jia & Jihui Hao. (2015) Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma. Oncotarget 6:29, pages 27816-27831.
Crossref
Crossref
Zhaojun Sun, Julien Fourcade, Ornella Pagliano, Joe-Marc Chauvin, Cindy Sander, John M. Kirkwood & Hassane M. Zarour. (2015) IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells. Cancer Research 75:8, pages 1635-1644.
Crossref
Crossref
Justin Rendleman, Matjaz Vogelsang, Anuj Bapodra, Christina Adaniel, Ines Silva, Duane Moogk, Carlos N Martinez, Nathaniel Fleming, Jerry Shields, Richard Shapiro, Russell Berman, Anna Pavlick, David Polsky, Yongzhao Shao, Iman Osman, Michelle Krogsgaard & Tomas Kirchhoff. (2015) Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma. Journal of Medical Genetics 52:4, pages 231-239.
Crossref
Crossref
Arlina P. Wiguna & Peter Walden. (2015)
Role of IL-10 and TGF-
β
in melanoma
. Experimental Dermatology 24:3, pages 209-214.
Crossref
Crossref
Louis Nuvagah Forti, Rose Njemini, Ingo Beyer, Elke Eelbode, Romain Meeusen, Tony Mets & Ivan Bautmans. (2014) Strength training reduces circulating interleukin-6 but not brain-derived neurotrophic factor in community-dwelling elderly individuals. AGE 36:5.
Crossref
Crossref
Li-Xin SunZhi-Bin LinXin-Suo DuanHai-Hua QiNing YangMin LiEn-Hong XingYu SunMin YuWei-Dong LiJie Lu. (2014)
Suppression of the Production of Transforming Growth Factor β1, Interleukin-10, and Vascular Endothelial Growth Factor in the B16F10 Cells by
Ganoderma lucidum
Polysaccharides
. Journal of Interferon & Cytokine Research 34:9, pages 667-675.
Crossref
Crossref
Sayan Mullick Chowdhury, Shruti Kanakia, Jimmy D. Toussaint, Mary D. Frame, Anthony M. Dewar, Kenneth R. Shroyer, William Moore & Balaji Sitharaman. (2013) In Vitro Hematological and In Vivo Vasoactivity Assessment of Dextran Functionalized Graphene. Scientific Reports 3:1.
Crossref
Crossref
Karolina Rudnicka, Agnieszka Matusiak, Eliza Miszczyk, Wiesława Rudnicka, Michał Tenderenda & Magdalena Chmiela. (2013)
Immunophenotype of peripheral blood natural killer cells and IL-10 serum levels in relation to
Helicobacter pylori
status
. APMIS 121:9, pages 806-813.
Crossref
Crossref
Elizabeth Ferreira Martinez, Marcelo Henrique Napimoga, Victor Angelo Martins Montalli, Ney Soares de Ara?jo & Vera Cavalcanti de Ara?jo. (2013) In vitro cytokine expression in in situ-like areas of malignant neoplasia. Archives of Oral Biology 58:5, pages 552-557.
Crossref
Crossref
Maria Fernanda Lucatelli Laurindo, Felipe Garutti Thies, Elizabeth Cristina Perez, Ronni Rômulo Novaes e Brito, Mario Mariano & Ana Flavia Popi. (2013) B16 melanoma cells increase B-1 cell survival, IL-10 production and radioresistance in vitro. Immunobiology 218:4, pages 609-619.
Crossref
Crossref
Carole Yolande PerrotDelphine JavelaudAlain Mauviel. (2013) Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma. Annals of Dermatology 25:2, pages 135.
Crossref
Crossref
Delphine Javelaud & Alain Mauviel. 2013. TGF-β in Human Disease. TGF-β in Human Disease
235
254
.
Filiz Namdar Pekiner, Gülderen Yanıkkaya Demirel, Mehmet Oğuz Borahan & Semih Özbayrak. (2012) Cytokine profiles in serum of patients with oral lichen planus. Cytokine 60:3, pages 701-706.
Crossref
Crossref
Tomonori Yaguchi, Yasufumi Goto, Kenji Kido, Hiroshi Mochimaru, Toshiharu Sakurai, Nobuo Tsukamoto, Chie Kudo-Saito, Tomonobu Fujita, Hidetoshi Sumimoto & Yutaka Kawakami. (2012) Immune Suppression and Resistance Mediated by Constitutive Activation of Wnt/β-Catenin Signaling in Human Melanoma Cells. The Journal of Immunology 189:5, pages 2110-2117.
Crossref
Crossref
Benjamin WeideHenning ZelbaEvelyna DerhovanessianAnnette PflugfelderThomas K. EigentlerAnna Maria Di GiacomoMichele MaioErik H.J.G. AarntzenI. Jolanda M. de VriesAntje SuckerDirk SchadendorfPetra BüttnerClaus GarbeGraham Pawelec. (2012) Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis. Journal of Clinical Oncology 30:15, pages 1835-1841.
Crossref
Crossref
Jochen Utikal, Jürgen C. Becker & Selma Ugurel. 2012. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
9
18
.
Shanique R. Palmer, Lori A. Erickson, Ilia Ichetovkin, Daniel J. Knauer & Svetomir N. Markovic. (2011) Circulating Serologic and Molecular Biomarkers in Malignant Melanoma. Mayo Clinic Proceedings 86:10, pages 981-990.
Crossref
Crossref
Amit Mahipal, Mizue Terai, David Berd, Inna Chervoneva, Kashyap Patel, Michael J. Mastrangelo & Takami Sato. (2011) Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine. Cancer Immunology, Immunotherapy 60:7, pages 1039-1045.
Crossref
Crossref
Li-Xin Sun, Zhi-Bin Lin, Xin-Suo Duan, Jie Lu, Zhi-Hua Ge, Xue-Jun Li, Min Li, En-Hong Xing, Jing Jia, Tian-Fei Lan & Wei-Dong Li. (2011)
Ganoderma lucidum
polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells
. Journal of Pharmacy and Pharmacology 63:5, pages 725-735.
Crossref
Crossref
Nancy Díaz-Valdés, María Basagoiti, Javier Dotor, Fernando Aranda, Iñaki Monreal, José Ignacio Riezu-Boj, Francisco Borrás-Cuesta, Pablo Sarobe & Esperanza Feijoó. (2011) Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression. Cancer Research 71:3, pages 812-821.
Crossref
Crossref
Rebecca J. Critchley-Thorne, Hongxiang Yu & Peter P. Lee. 2011. Immunologic Signatures of Rejection. Immunologic Signatures of Rejection
169
186
.
Roger Mouawad, Jean-Philippe Spano & David Khayat. (2010) Old and new serological biomarkers in melanoma: where we are in 2009. Melanoma Research 20:2, pages 67-76.
Crossref
Crossref
Ryosuke Hino, Kenji Kabashima, Yu Kato, Hiroaki Yagi, Motonobu Nakamura, Tasuku Honjo, Taku Okazaki & Yoshiki Tokura. (2010) Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma. Cancer 116:7, pages 1757-1766.
Crossref
Crossref
Ying-Ying Li, John W.-C. Chang, Ling-Ling Hsieh & Kun-Yun Yeh. (2010) Neutralization of interleukin (IL)-10 released by monocytes/macrophages enhances the up-regulatory effect of monocyte/macrophage-derived IL-6 on expressions of IL-6 and MUC1, and migration in HT-29 colon cancer cells. Cellular Immunology 265:2, pages 164-171.
Crossref
Crossref
Yuji Toiyama, Chikao Miki, Yasuhiro Inoue, Sayaka Minobe, Hiroko Urano & Masato Kusunoki. (2009) Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma. Surgery Today 40:1, pages 46-53.
Crossref
Crossref
Selma UgurelJochen UtikalJüurgen C Becker. (2009) Tumor Biomarkers in Melanoma. Cancer Control 16:3, pages 219-224.
Crossref
Crossref
Ewa Bien, Anna Balcerska, Elzbieta Adamkiewicz-Drozynska, Malgorzata Rapala, Malgorzata Krawczyk & Jan Stepinski. (2009) Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias. Clinical Biochemistry 42:10-11, pages 1144-1157.
Crossref
Crossref
Dan Ilkovitch & Diana M. Lopez. (2008) Immune modulation by melanoma-derived factors. Experimental Dermatology 17:12, pages 977-985.
Crossref
Crossref
R. Rätsep, K. Kingo, M. Karelson, E. Reimann, K. Raud, H. Silm, E. Vasar & S. Kõks. (2008)
Gene expression study of
IL10
family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera
. British Journal of Dermatology 159:6, pages 1275-1281.
Crossref
Crossref
T. Cacev, S. Radosevic, S. Krizanac & S. Kapitanovic. (2008) Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29:8, pages 1572-1580.
Crossref
Crossref
Jessica M. Faupel-Badger, La Creis Renee Kidd, Demetrius Albanes, Jarmo Virtamo, Karen Woodson & Joseph A. Tangrea. (2007) Association of IL-10 polymorphisms with prostate cancer risk and grade of disease. Cancer Causes & Control 19:2, pages 119-124.
Crossref
Crossref
Henry B. Koon & Michael B.Atkins. 2008. Molecular Targeting in Oncology. Molecular Targeting in Oncology
471
507
.
Paul B. Chapman. (2007) Melanoma Vaccines. Seminars in Oncology 34:6, pages 516-523.
Crossref
Crossref
Hitoe Torisu-Itakura, Jonathan H. Lee, Young Huynh, Xing Ye, Richard Essner & Donald L. Morton. (2007) Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients. Journal of Immunotherapy 30:8, pages 831-838.
Crossref
Crossref
Y.-S. Wei, X.-H. Kuang, Y.-H. Zhu, W.-B. Liang, Z.-H. Yang, S.-H. Tai, Y. Zhao & L. Zhang. (2007) Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Tissue Antigens 70:1, pages 12-17.
Crossref
Crossref
Meri-Sisko Vuoristo. (2007) The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma. Cancer Genetics and Cytogenetics 176:1, pages 54-57.
Crossref
Crossref
Jochen Utikal, Dirk Schadendorf & Selma Ugurel. (2007) Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies. Archives of Dermatological Research 298:10, pages 469-477.
Crossref
Crossref
Yvonne M. Saenger, Robert R. Jenq & Miguel-Angel Perales. 2007. General Principles of Tumor Immunotherapy. General Principles of Tumor Immunotherapy
67
121
.
C. EVANS, A. G. DALGLEISH & D. KUMAR. (2006) Review article: immune suppression and colorectal cancer. Alimentary Pharmacology and Therapeutics 24:8, pages 1163-1177.
Crossref
Crossref
María M. Barrio, Patricia T. de Motta, Julio Kaplan, Erika M. von Euw, Alicia I. Bravo, Reinaldo D. Chacón & José Mordoh. (2006) A Phase I Study of an Allogeneic Cell Vaccine (VACCIMEL) With GM-CSF in Melanoma Patients. Journal of Immunotherapy 29:4, pages 444-454.
Crossref
Crossref
Simone Mocellin, Francesco M Marincola & Howard A Young. (2005) Interleukin-10 and the immune response against cancer: a counterpoint. Journal of Leukocyte Biology 78:5, pages 1043-1051.
Crossref
Crossref
Jorge A. Martínez-Escribano, José A. Campillo, Antonio Piñero, José F. Fríasa, Paloma Sánchez-Pedreño, Raúl Corbalán, Alfredo Minguela & M. Rocío Álvarez. (2005) Estudio prospectivo de los niveles de citocinas séricas en pacientes con melanoma: valor pronóstico. Actas Dermo-Sifiliográficas 96:2, pages 83-91.
Crossref
Crossref
Dongxin Liu, Steven J. O'Day, Dongyun Yang, Peter Boasberg, Robert Milford, Tim Kristedja, Susan Groshen & Jeffrey Weber. (2005) Impact of Gene Polymorphisms on Clinical Outcome for Stage IV Melanoma Patients Treated with Biochemotherapy: An Exploratory Study. Clinical Cancer Research 11:3, pages 1237-1246.
Crossref
Crossref
S. Ugurel. (2005) Serummarker des malignen MelanomsSerum markers for melanoma. Der Hautarzt 56:2, pages 173-186.
Crossref
Crossref
Behnam Ebrahimi, Susan L. Tucker, Donghui Li, James L. Abbruzzese & Razelle Kurzrock. (2004) Cytokines in pancreatic carcinoma. Cancer 101:12, pages 2727-2736.
Crossref
Crossref
Gianni Gerlini, Adrian Tun-Kyi, Christa Dudli, Günter Burg, Nicola Pimpinelli & Frank O. Nestle. (2004) Metastatic Melanoma Secreted IL-10 Down-Regulates CD1 Molecules on Dendritic Cells in Metastatic Tumor Lesions. The American Journal of Pathology 165:6, pages 1853-1863.
Crossref
Crossref
Elliot Weiss, Adam Joseph Mamelak, Stephania La Morgia, Binghe Wang, Claudio Feliciani, Antonio Tulli & Daniel Nathan Sauder. (2004) The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases. Journal of the American Academy of Dermatology 50:5, pages 657-675.
Crossref
Crossref
K. Asadullah, W. Sterry & H. D. Volk. (2003) Interleukin-10 Therapy—Review of a New Approach. Pharmacological Reviews 55:2, pages 241-269.
Crossref
Crossref
Christopher E. Touloukian, Wolfgang W. Leitner, Rhonda E. Schnur, Paul F. Robbins, Yong Li, Scott Southwood, Alessandro Sette, Steven A. Rosenberg & Nicholas P. Restifo. (2003) Normal Tissue Depresses While Tumor Tissue Enhances Human T Cell Responses In Vivo to a Novel Self/Tumor Melanoma Antigen, OA1. The Journal of Immunology 170:3, pages 1579-1585.
Crossref
Crossref
Eric Alamartine, Patricia Berthoux, Christophe Mariat, François Berthoux & Frédéric Cambazard. (2003) Interleukin-10 Promoter Polymorphisms and Susceptibility to Skin Squamous Cell Carcinoma After Renal Transplantation. Journal of Investigative Dermatology 120:1, pages 99-103.
Crossref
Crossref
J. A. Martínez-Escribano, M. R. Moya-Quiles, M. Muro, O. Montes-Ares, T. Hernández-Caselles, J. F. Frías & M. R. Álvarez-López. (2002) Interleukin-10, interleukin-6 and interferon-γ gene polymorphisms in melanoma patients. Melanoma Research 12:5, pages 465-469.
Crossref
Crossref
Álvaro Ruibal Morell. (2002) Marcadores tumorales de secreción: situación actual. Medicina Clínica 118:19, pages 750-756.
Crossref
Crossref